Chemistry:Beta-Funaltrexamine

From HandWiki
Revision as of 19:23, 5 February 2024 by BotanyGa (talk | contribs) (linkage)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
β-Funaltrexamine
Beta-Funaltrexamine.svg
Names
IUPAC name
Methyl (2E)-4-{[17-(cyclopropylmethyl)-3,14-dihydroxy-4,5α-epoxymorphinan-6β-yl]amino}-4-oxobut-2-enoate
Systematic IUPAC name
Methyl (2E)-4-{[(4R,4aS,7R,7aR,12bS)-3-(cyclopropylmethyl)-4a,9-dihydroxy-2,3,4,4a,5,6,7,7a-octahydro-1H-4,12-methano[1]benzofuro[3,2-e]isoquinolin-7-yl]amino}-4-oxobut-2-enoate
Identifiers
3D model (JSmol)
Abbreviations β-FNA
ChEBI
ChEMBL
ChemSpider
KEGG
Properties
C25H30N2O6
Molar mass 454.523 g·mol−1
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
Infobox references

β-Funaltrexamine (β-FNA) is an irreversible (covalently bonding) opioid antagonist that was used to create the first crystal structure of the μ-opioid receptor.[1] Chemically, it is a naltrexone derivative with a methyl-fumaramide group in the 6-position.

See also

References